🔎 Trials Near Me

Domov › Rak endometrija › Colorado

Klinične študije za Rak endometrija v Colorado

30 študij za Rak endometrija išče udeležence na lokacijah v Colorado.

Mesta v Colorado

Uradno besedilo študije (angleško)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UCHealth University of Colorado Hospital, Aurora
  • Poudre Valley Hospital, Fort Collins
  • Cancer Care and Hematology-Fort Collins, Fort Collins
  • in še 2
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Rocky Mountain Cancer Center, Denver
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 2. okt. 2026 · NCT07198074

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • SCRI at HealthOne, Denver
Vključevanje udeležencevFaza 1
Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957

DESTINY-PANTUMOUR04

  • Research Site, Boulder
Vključevanje udeležencevOpazovalna študija
Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • UCHealth University of Colorado Hospital, Aurora
  • AdventHealth Porter, Denver
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  • GSK Investigational Site, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07213609

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Colorado, Aurora
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  • SCRI at Denver Health, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06515613

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  • SCRI at HCA Health One, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07186842

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • SCRI Denver, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute (SCRI) at HealthONE-Denver, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07383506

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Colorado, Aurora
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18–130 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • University of Colorado, Aurora
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 21. avg. 2026 · NCT05548296

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Colorado, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

  • Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06840886

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Rocky Mountain Cancer Center, Denver
  • Sarah Cannon Research Institute at HealthONE, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT04657068

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • Rocky Mountain Cancer Center, Littleton
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06695845

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT05768139

Integrated Cancer Repository for Cancer Research

  • Advent Health, Greenwood Village
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • Sarah Cannon Research Institute at HealthONE, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. jun. 2026 · NCT07503808

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06239194

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

  • Dren Investigational Site, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 7. jan. 2026 · NCT06999187

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • University of Colorado Cancer Center, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 4. nov. 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Aurora
  • Massive Bio SYNERGY-AI site, Denver
  • Massive Bio SYNERGY-AI site, Littleton
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

  • HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2025 · NCT05669430

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.